• Conference call and webcast to be held tomorrow, January 2, at 8:30am ET (5:30am PT)LA JOLLA, Calif.--(BUSINESS WIRE)--$LBPH #Epilepsy--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced...

– PADCEV plus pembrolizumab approved based on groundbreaking EV-302 trial – – Confirmatory trial found PADCEV plus pembrolizumab nearly doubled median overall survival compared to standard of care platinum-based chemotherapy –NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas...

SBM Offshore has secured a US$210 million revolving credit facility (RCF) to finance the construction of Fast4Ward® Multi-Purpose Floater (MPF) hulls, the company said in December 15 release.  The tenor of the RCF is eighteen months with an extension option...

SAR443579/IPH6101, ANKET® platform lead asset, is a first-in-class NKp46/CD16-based NK cell engager targeting CD123 from a joint research collaboration between Innate Pharma and Sanofi, under development by Sanofi SAR443579 induced clinical benefit in patients with R/R AML with 5 complete...

Results confirm promising clinical activity, durable responses and favorable safety of lacutamab in heavily pretreated post-mogamulizumab Sézary Syndrome patients. Virtual KOL event will be held on Tuesday, December 12, 2023 at 7:00AM PST (4:00PM CET) MARSEILLE, France--(BUSINESS WIRE)--#immunotherapy--Innate Pharma SA (Euronext...

This collaboration aims at accelerating the discovery of small molecules across various therapeutic areas, leveraging its unique Deep Physics platform combined with Generative AI. AQEMIA to receive up to a total of $140M in upfront and milestones across all...

A single dose of measles and rubella (MR) vaccine delivered to adults by the Vaxxas high-density microarray patch (HD-MAP) provided antibody responses comparable to the same vaccine delivered by needle and syringe. Higher antibody responses in study participants with the...

Positive results from the TELLOMAK Phase 2 Trial with lacutamab in heavily pretreated patients with relapsed and refractory Sézary syndrome selected for oral presentation Preliminary monotherapy lacutamab Phase 1b clinical data and pre-clinical combinability data in patients with peripheral T-cell...

ExxonMobil aims to churn out even more discoveries in Guyana’s Stabroek block with three wildcats planned for the new year, said its senior vice president, Neil Chapman, on October 27.  Exxon has already racked up a resource count of over...

Avutometinib + Sotorasib Combination Demonstrated Preliminary Efficacy with Confirmed Responses in both KRAS G12C Inhibitor Resistant and Naïve Patients No New Safety Signals Observed in Combination; Most Treatment-Related Adverse Events Mild to Moderate Enrollment of Patients Naïve to or Previously Treated...